TATomohiko Ai

Tomohiko Ai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tomohiko Ai has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Drug-induced Brugada ECG Changes Associated With A Novel SCN5A Mutation In A Patient With Atrial Arrhythmias

    by Kaveh Samani, Tomohiko Ai, Takeshi Ueyama, Takeru Makiyama, Matteo Vatta, Yoshiro Sohma, Yutao Xi, Hideki Itoh, Minoru Horie, Akihiko Shimizu, et al.

  • α-1-Syntrophin Mutation and the Long-QT Syndrome

    by Geru Wu, Tomohiko Ai, Jeffrey J. Kim, Bhagyalaxmi Mohapatra, Yutao Xi, Zhaohui Li, Shahrzad Abbasi, Enkhsaikhan Purevjav, Kaveh Samani, Michael J Ackerman, et al.

    Background— Long-QT syndrome (LQTS) is an inherited disorder associated with sudden cardiac death. The cytoskeletal protein syntrophin-α 1 (SNTA1) is known to interact with the cardiac sodium channel (hNa v 1.5), and we hypothesized that SNTA1 mutations might cause phenotypic LQTS in patients with genotypically normal hNa v 1.5 by secondarily disturbing sodium channel function. Methods and Results— Mutational analysis of SNTA1 was performed on 39 LQTS patients (QTc≥480 ms) with previously negative genetic screening for the known LQTS-causing genes. We identified a novel A257G- SNTA1 missense mutation, which affects a highly conserved residue, in 3 unrelated LQTS probands but not in 400 ethnic-matched control alleles. Only 1 of these probands had a preexisting family history of LQTS and sudden death with an additional intronic variant in KCNQ1. Electrophysiological analysis was performed using HEK-293 cells stably expressing hNa v 1.5 and transiently transfected with either wild-type or mutant SNTA1 and, in neonatal rat cardiomyocytes, transiently transfected with either wild-type or mutant SNTA1. In both HEK-293 cells and neonatal rat cardiomyocytes, increased peak sodium currents were noted along with a 10-mV negative shift of the onset and peak of currents of the current-voltage relationships. In addition, A257G-SNTA1 shifted the steady-state activation ( V h ) leftward by 9.4 mV, whereas the voltage-dependent inactivation kinetics and the late sodium currents were similar to wild-type SNTA1. Conclusion— SNTA1 is a new susceptibility gene for LQTS. A257G- SNTA1 can cause gain-of-function of Na v 1.5 similar to the LQT3.


  • Successful radiofrequency current catheter ablation of accessory atrioventricular pathway in Ebstein's anomaly using electroanatomic mapping.

    by Tomohiko Ai, Shigeru Ikeguchi, Masato Watanuki, Naoki Amaya, Tomonori Ninomiya, Minoru Horie, Chuichi Kawai


  • Radiofrequency catheter ablation to WPW syndrome: Analysis of multiple accessory atrioventricular pathways.

    by Shigeru Ikeguchi, Masato Watanuki, Rei Takeoka, Kazumi Okuda, Noboru Ishikawa, Tetsuo Hashimoto, Minoru Horie, Kazuhiko Oobayashi, Kunihiko Tsuchiya, Takashi Washizuka, et al.

    高周波力テーテル・アブレーションを施行したWPW症候群74症例につき複数副伝導路の有無とその特徴を検討した.74症例中12例が複数副伝導路所見を有した.左心側では6例12本の複数副伝導路を認めうち3例は副伝導路間距離が2cm未満の複数コンポーネントKent束であった.一方右心側では5例15本の複数副伝導路がみられたが全例副伝導路間距離20m以上の複数Kent束であり, Ebstein奇形やSTOW Kent束, Mahaim束などのvariant preexoitation合併例がみられた.1例で左右両心側に副伝導路を認めた.顕性WPW症候群では41例中10例 (24%) と潜在性WPW症候群 (33例中1例: 3%) に比べ有意に高率に複数副伝導路所見を認めた (p<0.01) .複数副伝導路群におけるそれぞれの副伝導路に対するカテーテル・アブレーションの急性期成功率及び慢性期再発率は単数副伝導路群と差がなく, 複数副伝導路例に対しても高周波力テーテル・アブレーションは積極的に試みるべき治療法と考えられる.